Literature DB >> 7479647

Circulating trans-sialidase activity and trans-sialidase-inhibiting antibodies in Trypanosoma cruzi-infected mice.

N M Alcântara-Neves1, L C Pontes-de-Carvalho.   

Abstract

Parasite-derived trans-sialidase (TS) activity was demonstrated in the serum and blood of Trypanosoma cruzi-infected mice. Serum TS activity levels correlated well with parasitemia in BALB/c and Swiss mice during the initial stages of the infection. However, in later stages the TS activity levels decreased despite increasing parasitemia. This coincided with the appearance of circulating TS antibodies. On the other hand, there was always a good correlation between TS activity and parasitemia in athymic nude mice. Sera from mice with high parasitemia and low TS activity inhibited TS activity in vitro. The inhibition was also observed with purified serum IgG, and it was absorbed by staphylococcal protein A, indicating that it was caused by anti-TS IgG antibodies. These antibodies inhibited the enzymatic activity of insolubilized TS, indicating that they act by interfering with the catalytic site rather than by aggregating the enzyme. The presence of inhibitory antibodies, however, did not prevent the progression of parasitemia in BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7479647     DOI: 10.1007/bf00932022

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  23 in total

1.  A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.

Authors:  P Libby; J Alroy; M E Pereira
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  The Trypanosoma cruzi neuraminidase contains sequences similar to bacterial neuraminidases, YWTD repeats of the low density lipoprotein receptor, and type III modules of fibronectin.

Authors:  M E Pereira; J S Mejia; E Ortega-Barria; D Matzilevich; R P Prioli
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

4.  A novel cell surface trans-sialidase of Trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells.

Authors:  S Schenkman; M S Jiang; G W Hart; V Nussenzweig
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

5.  Substrate specificity of the Trypanosoma cruzi trans-sialidase.

Authors:  F Vandekerckhove; S Schenkman; L Pontes de Carvalho; S Tomlinson; M Kiso; M Yoshida; A Hasegawa; V Nussenzweig
Journal:  Glycobiology       Date:  1992-12       Impact factor: 4.313

6.  Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome.

Authors:  M Ming; M Chuenkova; E Ortega-Barria; M E Pereira
Journal:  Mol Biochem Parasitol       Date:  1993-06       Impact factor: 1.759

7.  A developmentally regulated neuraminidase activity in Trypanosoma cruzi.

Authors:  M E Pereira
Journal:  Science       Date:  1983-03-25       Impact factor: 47.728

8.  Serum neuraminidase activity and hematological alterations in acute human Chagas' disease.

Authors:  E H de Titto; F G Araujo
Journal:  Clin Immunol Immunopathol       Date:  1988-01

9.  Trypanosoma cruzi trans-sialidase and neuraminidase activities can be mediated by the same enzymes.

Authors:  S Schenkman; L Pontes de Carvalho; V Nussenzweig
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

10.  Desialylation of lysosomal membrane glycoproteins by Trypanosoma cruzi: a role for the surface neuraminidase in facilitating parasite entry into the host cell cytoplasm.

Authors:  B F Hall; P Webster; A K Ma; K A Joiner; N W Andrews
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

View more
  1 in total

1.  Epitope mapping of trans-sialidase from Trypanosoma cruzi reveals the presence of several cross-reactive determinants.

Authors:  T A Pitcovsky; J Mucci; P Alvarez; M S Leguizamón; O Burrone; P M Alzari; O Campetella
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.